BACKGROUND: Coping strategies may be important factors influencing quality of life (QOL), depression, and hopelessness. However, most studies on this issue were performed in patients still undergoing anticancer treatment. Unknown is which coping strategies are of importance for palliative-cancer patients who no longer receive treatment. OBJECTIVE: The objectives of this study were to assess coping strategies in curatively treated and palliative-cancer patients no longer receiving anticancer treatment and to examine the relation of these coping strategies with QOL, depression, and hopelessness. METHODS: A descriptive research design was used. Ninety-two curative and 59 palliative patients filled out the COPE-Easy abbreviated version, the European Organisation for Research-and-Treatment of Cancer QOL-Questionnaire version 2.0, Beck Depression Inventory for Primary Care, and Beck Hopelessness Scale. RESULTS: In both curative and palliative patients, active coping strategies and acceptance were beneficial in terms of QOL, depression, and hopelessness, unlike avoidant coping strategies and venting of emotions. Palliative patients scored higher on the coping strategy, seeking moral support. For the outcome variable, emotional functioning, significant interactions were observed between the variable, curative/palliative care setting, and the coping strategy, seeking moral support. For the outcome variable, role functioning, significant interactions were observed between the variable, curative/palliative care setting, and the coping strategy, waiting. CONCLUSIONS: Coping strategies were significantly correlated to QOL, depression, and hopelessness. However, this correlation differed in the curative and palliative, end-of-life care setting. IMPLICATIONS FOR PRACTICE: The observed relations between coping strategies, QOL, depression, and hopelessness give room to cognitive-behavioral nursing interventions. Specific attention is needed for differences in coping strategies between curative and palliative patients.
BACKGROUND: Coping strategies may be important factors influencing quality of life (QOL), depression, and hopelessness. However, most studies on this issue were performed in patients still undergoing anticancer treatment. Unknown is which coping strategies are of importance for palliative-cancerpatients who no longer receive treatment. OBJECTIVE: The objectives of this study were to assess coping strategies in curatively treated and palliative-cancerpatients no longer receiving anticancer treatment and to examine the relation of these coping strategies with QOL, depression, and hopelessness. METHODS: A descriptive research design was used. Ninety-two curative and 59 palliative patients filled out the COPE-Easy abbreviated version, the European Organisation for Research-and-Treatment of Cancer QOL-Questionnaire version 2.0, Beck Depression Inventory for Primary Care, and Beck Hopelessness Scale. RESULTS: In both curative and palliative patients, active coping strategies and acceptance were beneficial in terms of QOL, depression, and hopelessness, unlike avoidant coping strategies and venting of emotions. Palliative patients scored higher on the coping strategy, seeking moral support. For the outcome variable, emotional functioning, significant interactions were observed between the variable, curative/palliative care setting, and the coping strategy, seeking moral support. For the outcome variable, role functioning, significant interactions were observed between the variable, curative/palliative care setting, and the coping strategy, waiting. CONCLUSIONS: Coping strategies were significantly correlated to QOL, depression, and hopelessness. However, this correlation differed in the curative and palliative, end-of-life care setting. IMPLICATIONS FOR PRACTICE: The observed relations between coping strategies, QOL, depression, and hopelessness give room to cognitive-behavioral nursing interventions. Specific attention is needed for differences in coping strategies between curative and palliative patients.
Authors: Joseph A Greer; Allison J Applebaum; Juliet C Jacobsen; Jennifer S Temel; Vicki A Jackson Journal: J Clin Oncol Date: 2020-02-05 Impact factor: 44.544
Authors: I Ghanem; B Castelo; P Jimenez-Fonseca; A Carmona-Bayonas; O Higuera; C Beato; T García; R Hernández; C Calderon Journal: Clin Transl Oncol Date: 2019-05-10 Impact factor: 3.405
Authors: Alaina J Brown; Charlotte C Sun; Diana Urbauer; Donna S Zhukovsky; Charles Levenback; Michael Frumovitz; Premal H Thaker; Diane C Bodurka; Lois M Ramondetta Journal: Support Care Cancer Date: 2014-12-18 Impact factor: 3.603
Authors: Kuang-Hsi Chang; Wen-Li Hwang; Chih-Hsin Muo; Chung Y Hsu; Chieh-Lin Jerry Teng Journal: Support Care Cancer Date: 2016-08-09 Impact factor: 3.603
Authors: Li-Fang Chang; Chi-Kang Lin; Li-Fen Wu; Ching-Liang Ho; Yi-Ling Lu; Hsueh-Hsing Pan Journal: Int J Environ Res Public Health Date: 2021-05-05 Impact factor: 3.390
Authors: Vida Ghodraty-Jabloo; Shabbir M H Alibhai; Henriette Breunis; Martine T E Puts Journal: Support Care Cancer Date: 2015-11-05 Impact factor: 3.359
Authors: Alexander J Pennings; Merel L Kimman; Anke H C Gielen; Geerard L Beets; Jarno Melenhorst; Stephanie O Breukink Journal: Colorectal Dis Date: 2021-08-07 Impact factor: 3.917